European regulators said that a Duchenne gene therapy should not be approved, imperiling the treatment that is also facing ...

The federal government has approved more than $4 billion in extra Medicaid funds that will be routed to hospitals, doctors, ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

Preauthorization is about to enter the lives of many seniors who have chosen traditional Medicare over MA, write former CMS ...

As the Trump administration reshapes biomedicine, it wants to change how scientists test drug safety: animal research.

As gene therapy maker Sarepta Therapeutics tangles with FDA over its Duchenne treatment, patients and their families are ...

President Trump wants to make it easier to involuntarily treat people with serious mental illnesses, but critics say the ...

UnitedHealth Group on Thursday confirmed the Department of Justice has launched both criminal and civil investigations into ...

Former Biden global health security lead Stephanie Psaki asks: Why would the Trump administration reject a deal that ...

Columbia University agreed Wednesday to pay more than $220 million in a deal with the Trump administration to restore federal ...

To suggest Sarepta Therapeutics may not survive its gene therapy crisis is a sobering claim to make, STAT's Adam Feuerstein ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...